1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Gargaro, A.R. Soteriou, A. Frenkiel, T.A. Bauer, C.J. Birdsall, B. Polshakov, V.I. Barsukov, I.L. Roberts, G.C.K. Feeney, J. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C20 H22 N8 O5 454.439 METHOTREXATE non-polymer C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking UK J.Mol.Biol. JMOBAK 0070 0022-2836 277 119 134 10.1006/jmbi.1997.1560 9514736 The solution structure of the complex of Lactobacillus casei dihydrofolate reductase with methotrexate. 1998 US J.Biol.Chem. JBCHA3 0071 0021-9258 257 13650 Crystal Structures of Escherichia Coli and Lactobacillus Casei Dihydrofolate Reductase Refined at 1.7 A Resolution. I. General Features and Binding of Methotrexate 1982 10.2210/pdb1ao8/pdb pdb_00001ao8 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 18331.594 DIHYDROFOLATE REDUCTASE 1.5.1.3 1 man polymer 454.439 METHOTREXATE 1 syn non-polymer DHFR no no TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK KA TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK KA A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n Lactobacillus METHOTREXATE-RESISTANT Escherichia sample 1582 Lactobacillus casei 562 Escherichia coli NF1 PMT702 database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_site repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1998-02-25 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-16 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_site.pdbx_auth_asym_id _struct_site.pdbx_auth_comp_id _struct_site.pdbx_auth_seq_id Y BNL 1997-07-22 REL REL MTX METHOTREXATE NO NOE VIOLATION 21 21 COSY NOESY ROESY HNHA HNHB HSQC 3D-1H/13C-NOESY-HMQC 3D-1H/ 15N-HMQC-NOESY-HMQC 1H/15N-NOESY-HSQC 4D-13C/ 13C-EDITED-NOESY 150 mM 6.5 308 K REFINEMENT DETAILS CAN BE FOUND IN THE J. MOL. BIOL. PAPER, GARGARO ET AL. CITED ABOVE. simulated annealing BRUNGER refinement X-PLOR structure solution XPLOR 600 Varian UNITY MTX 170 2 MTX MTX 170 A THR 1 n 1 THR 1 A ALA 2 n 2 ALA 2 A PHE 3 n 3 PHE 3 A LEU 4 n 4 LEU 4 A TRP 5 n 5 TRP 5 A ALA 6 n 6 ALA 6 A GLN 7 n 7 GLN 7 A ASP 8 n 8 ASP 8 A ARG 9 n 9 ARG 9 A ASP 10 n 10 ASP 10 A GLY 11 n 11 GLY 11 A LEU 12 n 12 LEU 12 A ILE 13 n 13 ILE 13 A GLY 14 n 14 GLY 14 A LYS 15 n 15 LYS 15 A ASP 16 n 16 ASP 16 A GLY 17 n 17 GLY 17 A HIS 18 n 18 HIS 18 A LEU 19 n 19 LEU 19 A PRO 20 n 20 PRO 20 A TRP 21 n 21 TRP 21 A HIS 22 n 22 HIS 22 A LEU 23 n 23 LEU 23 A PRO 24 n 24 PRO 24 A ASP 25 n 25 ASP 25 A ASP 26 n 26 ASP 26 A LEU 27 n 27 LEU 27 A HIS 28 n 28 HIS 28 A TYR 29 n 29 TYR 29 A PHE 30 n 30 PHE 30 A ARG 31 n 31 ARG 31 A ALA 32 n 32 ALA 32 A GLN 33 n 33 GLN 33 A THR 34 n 34 THR 34 A VAL 35 n 35 VAL 35 A GLY 36 n 36 GLY 36 A LYS 37 n 37 LYS 37 A ILE 38 n 38 ILE 38 A MET 39 n 39 MET 39 A VAL 40 n 40 VAL 40 A VAL 41 n 41 VAL 41 A GLY 42 n 42 GLY 42 A ARG 43 n 43 ARG 43 A ARG 44 n 44 ARG 44 A THR 45 n 45 THR 45 A TYR 46 n 46 TYR 46 A GLU 47 n 47 GLU 47 A SER 48 n 48 SER 48 A PHE 49 n 49 PHE 49 A PRO 50 n 50 PRO 50 A LYS 51 n 51 LYS 51 A ARG 52 n 52 ARG 52 A PRO 53 n 53 PRO 53 A LEU 54 n 54 LEU 54 A PRO 55 n 55 PRO 55 A GLU 56 n 56 GLU 56 A ARG 57 n 57 ARG 57 A THR 58 n 58 THR 58 A ASN 59 n 59 ASN 59 A VAL 60 n 60 VAL 60 A VAL 61 n 61 VAL 61 A LEU 62 n 62 LEU 62 A THR 63 n 63 THR 63 A HIS 64 n 64 HIS 64 A GLN 65 n 65 GLN 65 A GLU 66 n 66 GLU 66 A ASP 67 n 67 ASP 67 A TYR 68 n 68 TYR 68 A GLN 69 n 69 GLN 69 A ALA 70 n 70 ALA 70 A GLN 71 n 71 GLN 71 A GLY 72 n 72 GLY 72 A ALA 73 n 73 ALA 73 A VAL 74 n 74 VAL 74 A VAL 75 n 75 VAL 75 A VAL 76 n 76 VAL 76 A HIS 77 n 77 HIS 77 A ASP 78 n 78 ASP 78 A VAL 79 n 79 VAL 79 A ALA 80 n 80 ALA 80 A ALA 81 n 81 ALA 81 A VAL 82 n 82 VAL 82 A PHE 83 n 83 PHE 83 A ALA 84 n 84 ALA 84 A TYR 85 n 85 TYR 85 A ALA 86 n 86 ALA 86 A LYS 87 n 87 LYS 87 A GLN 88 n 88 GLN 88 A HIS 89 n 89 HIS 89 A PRO 90 n 90 PRO 90 A ASP 91 n 91 ASP 91 A GLN 92 n 92 GLN 92 A GLU 93 n 93 GLU 93 A LEU 94 n 94 LEU 94 A VAL 95 n 95 VAL 95 A ILE 96 n 96 ILE 96 A ALA 97 n 97 ALA 97 A GLY 98 n 98 GLY 98 A GLY 99 n 99 GLY 99 A ALA 100 n 100 ALA 100 A GLN 101 n 101 GLN 101 A ILE 102 n 102 ILE 102 A PHE 103 n 103 PHE 103 A THR 104 n 104 THR 104 A ALA 105 n 105 ALA 105 A PHE 106 n 106 PHE 106 A LYS 107 n 107 LYS 107 A ASP 108 n 108 ASP 108 A ASP 109 n 109 ASP 109 A VAL 110 n 110 VAL 110 A ASP 111 n 111 ASP 111 A THR 112 n 112 THR 112 A LEU 113 n 113 LEU 113 A LEU 114 n 114 LEU 114 A VAL 115 n 115 VAL 115 A THR 116 n 116 THR 116 A ARG 117 n 117 ARG 117 A LEU 118 n 118 LEU 118 A ALA 119 n 119 ALA 119 A GLY 120 n 120 GLY 120 A SER 121 n 121 SER 121 A PHE 122 n 122 PHE 122 A GLU 123 n 123 GLU 123 A GLY 124 n 124 GLY 124 A ASP 125 n 125 ASP 125 A THR 126 n 126 THR 126 A LYS 127 n 127 LYS 127 A MET 128 n 128 MET 128 A ILE 129 n 129 ILE 129 A PRO 130 n 130 PRO 130 A LEU 131 n 131 LEU 131 A ASN 132 n 132 ASN 132 A TRP 133 n 133 TRP 133 A ASP 134 n 134 ASP 134 A ASP 135 n 135 ASP 135 A PHE 136 n 136 PHE 136 A THR 137 n 137 THR 137 A LYS 138 n 138 LYS 138 A VAL 139 n 139 VAL 139 A SER 140 n 140 SER 140 A SER 141 n 141 SER 141 A ARG 142 n 142 ARG 142 A THR 143 n 143 THR 143 A VAL 144 n 144 VAL 144 A GLU 145 n 145 GLU 145 A ASP 146 n 146 ASP 146 A THR 147 n 147 THR 147 A ASN 148 n 148 ASN 148 A PRO 149 n 149 PRO 149 A ALA 150 n 150 ALA 150 A LEU 151 n 151 LEU 151 A THR 152 n 152 THR 152 A HIS 153 n 153 HIS 153 A THR 154 n 154 THR 154 A TYR 155 n 155 TYR 155 A GLU 156 n 156 GLU 156 A VAL 157 n 157 VAL 157 A TRP 158 n 158 TRP 158 A GLN 159 n 159 GLN 159 A LYS 160 n 160 LYS 160 A LYS 161 n 161 LYS 161 A ALA 162 n 162 ALA 162 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A O VAL 74 A O VAL 74 A N VAL 61 A N VAL 61 A O THR 58 A O THR 58 A N MET 39 A N MET 39 A O ILE 38 A O ILE 38 A N VAL 95 A N VAL 95 A O LEU 94 A O LEU 94 A N ALA 2 A N ALA 2 A N PHE 3 A N PHE 3 A O THR 112 A O THR 112 A O LEU 113 A O LEU 113 A N TRP 158 A N TRP 158 A O GLN 159 A O GLN 159 A N PHE 136 A N PHE 136 1 A LEU 23 -113.87 78.79 1 A GLN 33 -98.61 32.92 1 A THR 34 -150.30 -48.26 1 A GLU 56 80.52 -11.31 1 A ASP 67 -148.17 31.55 1 A ALA 70 -165.50 110.46 1 A HIS 77 -144.34 36.02 1 A PHE 106 -94.83 56.77 1 A ASP 108 -98.27 34.13 1 A ASP 109 -163.66 76.92 1 A ASP 135 -97.26 38.25 1 A ASP 146 -115.62 -167.06 1 A LEU 151 -96.40 31.17 2 A GLN 33 -98.78 37.28 2 A THR 34 -146.41 -45.28 2 A HIS 77 -150.24 36.16 2 A PHE 106 -94.88 52.13 2 A ASP 109 -109.92 67.69 2 A ASP 111 -133.76 -64.21 2 A ASP 135 -99.27 35.81 2 A LEU 151 -96.72 31.46 3 A ILE 13 -145.72 28.70 3 A LYS 15 -163.58 114.86 3 A GLN 33 -103.10 41.17 3 A THR 34 -149.99 -46.20 3 A HIS 77 -149.88 36.48 3 A ASP 78 -170.55 127.19 3 A PHE 106 -98.15 47.47 3 A ASP 111 -130.64 -69.56 3 A ASP 135 -97.96 35.40 4 A ILE 13 -140.08 30.86 4 A GLN 33 -97.17 36.03 4 A THR 34 -150.07 -46.90 4 A HIS 77 -149.91 33.08 4 A PHE 106 -102.23 40.29 4 A ASP 108 -98.61 31.40 4 A ASP 109 -160.93 77.10 4 A ASP 111 -128.86 -55.21 4 A ASP 135 -98.02 30.59 4 A SER 141 -165.98 97.43 4 A ASP 146 -119.48 -166.84 5 A THR 34 -146.87 -45.41 5 A ARG 57 -177.29 144.70 5 A HIS 64 -99.69 35.82 5 A ASP 78 -176.15 136.39 5 A ASP 109 -157.27 51.39 5 A ASP 135 -96.80 40.20 5 A SER 141 -169.72 116.42 5 A ASP 146 -101.08 -168.66 5 A LEU 151 -96.35 33.83 6 A GLN 33 -99.78 38.73 6 A THR 34 -148.70 -45.38 6 A ASP 67 -164.92 -48.05 6 A HIS 77 -149.35 36.02 6 A ASP 78 -170.74 138.48 6 A PHE 106 -102.00 40.16 6 A ASP 108 -98.80 33.34 6 A ASP 109 -157.87 73.08 7 A ALA 2 -161.51 119.90 7 A LYS 15 -162.73 118.19 7 A GLN 33 -98.94 38.10 7 A THR 34 -150.04 -44.75 7 A ASP 67 -157.22 -47.18 7 A HIS 77 -144.41 30.27 7 A HIS 89 -116.55 77.15 7 A ASP 108 -97.69 36.08 7 A ASP 109 -161.03 72.53 7 A ASP 125 -133.73 -45.40 7 A ASP 135 -96.66 35.59 7 A SER 141 -170.04 86.79 8 A LEU 4 -161.46 107.27 8 A GLN 33 -94.34 43.61 8 A THR 34 -150.15 -53.52 8 A HIS 64 -98.08 37.53 8 A ASP 67 -141.91 33.42 8 A HIS 77 -149.06 33.65 8 A ASP 78 -173.53 136.74 8 A HIS 89 -116.00 76.83 8 A PHE 106 -100.56 41.68 8 A ASP 109 -114.97 70.23 8 A ASP 111 -133.05 -70.50 8 A ASP 135 -97.76 35.97 8 A TYR 155 -65.74 98.57 9 A ILE 13 -145.96 31.09 9 A GLN 33 -102.00 42.69 9 A THR 34 -150.00 -45.20 9 A GLU 66 -98.73 31.76 9 A HIS 77 -149.88 32.24 9 A PHE 106 -101.71 45.99 9 A ASP 108 -98.02 35.86 9 A ASP 109 -160.99 73.08 9 A ASP 135 -97.82 36.98 9 A LYS 161 -62.06 -178.47 10 A LEU 4 -161.32 109.74 10 A GLN 33 -98.35 35.70 10 A THR 34 -144.05 -45.34 10 A ASP 109 -157.09 64.82 11 A GLN 33 -98.02 36.37 11 A THR 34 -149.51 -46.24 11 A HIS 77 -143.55 34.71 11 A PHE 106 -98.21 37.26 11 A ASP 108 -99.19 33.06 11 A ASP 109 -163.21 77.09 11 A ASP 111 -127.53 -58.73 11 A VAL 139 -128.14 -64.79 12 A LYS 15 -169.60 101.94 12 A GLN 33 -97.60 39.47 12 A THR 34 -149.23 -44.77 12 A HIS 77 -150.16 38.32 12 A ASP 108 -98.66 33.55 12 A ASP 109 -159.34 72.46 12 A ASP 125 -146.77 -46.39 12 A ASP 135 -97.19 38.69 13 A LYS 15 -162.73 105.16 13 A GLN 33 -97.86 39.64 13 A THR 34 -148.79 -44.42 13 A HIS 77 -148.79 37.35 13 A HIS 89 -115.93 77.28 13 A ASP 109 -116.02 70.88 13 A ASP 135 -97.60 37.77 13 A ALA 150 -97.69 34.83 13 A LEU 151 -147.08 29.02 14 A LYS 15 -162.11 116.55 14 A THR 34 -149.86 -45.65 14 A PHE 106 -97.28 52.33 14 A ASP 108 -98.10 31.31 14 A ASP 109 -158.75 76.30 14 A ALA 150 -97.94 30.58 15 A THR 34 -148.55 -46.15 15 A GLU 66 -98.61 30.29 15 A HIS 77 -149.54 33.77 15 A ASP 109 -109.70 67.62 15 A ALA 119 -124.71 -51.19 15 A VAL 139 -124.76 -63.04 15 A LEU 151 -97.38 32.34 16 A GLN 33 -101.76 40.15 16 A THR 34 -150.12 -45.31 16 A HIS 64 -97.52 36.40 16 A GLU 66 -99.26 34.94 16 A HIS 77 -150.02 32.59 16 A ASP 78 -176.94 143.56 16 A PHE 106 -103.08 44.24 16 A ASP 109 -116.73 70.77 16 A VAL 139 -127.37 -64.92 17 A ASP 8 -115.55 -169.28 17 A GLN 33 -97.73 37.18 17 A THR 34 -150.15 -45.84 17 A ASP 108 -101.41 52.31 17 A ASP 109 -149.01 39.19 17 A ASP 135 -96.94 37.79 18 A THR 34 -149.98 -45.38 18 A HIS 77 -148.72 36.08 18 A ASP 78 -172.59 133.56 18 A ASP 109 -104.55 65.02 18 A ASP 111 -137.02 -70.81 18 A ASP 135 -98.51 33.10 18 A ASP 146 -102.82 -165.73 18 A LEU 151 -97.35 32.67 19 A LYS 15 -164.71 115.10 19 A GLN 33 -97.65 37.81 19 A THR 34 -148.12 -46.42 19 A ASP 108 -98.51 32.79 19 A ASP 109 -159.17 75.05 19 A ASP 135 -97.03 37.08 20 A LEU 23 -114.01 76.63 20 A GLN 33 -97.66 37.76 20 A THR 34 -149.20 -48.99 20 A ARG 57 179.71 166.48 20 A HIS 64 -119.26 50.84 20 A HIS 77 -149.13 34.13 20 A ASP 108 -98.34 34.54 20 A ASP 109 -152.25 66.00 20 A ASP 135 -98.18 37.26 21 A LYS 15 -170.85 109.56 21 A GLN 33 -97.13 40.19 21 A THR 34 -148.38 -45.40 21 A GLU 66 -99.35 31.42 21 A HIS 77 -150.20 38.82 21 A PHE 106 -100.78 40.52 21 A ASP 109 -161.00 77.23 21 A ASP 111 -123.36 -58.90 21 A ASP 125 -148.08 -46.09 21 A ASP 135 -97.52 33.77 model building X-PLOR refinement X-PLOR phasing X-PLOR DIHYDROFOLATE REDUCTASE COMPLEXED WITH METHOTREXATE, NMR, 21 STRUCTURES 1 Y N 2 N N A PRO 24 A PRO 24 HELX_P A ALA 32 A ALA 32 1 HB 9 A ARG 43 A ARG 43 HELX_P A SER 48 A SER 48 1 HC 6 A VAL 79 A VAL 79 HELX_P A GLN 88 A GLN 88 1 HE 10 A ALA 100 A ALA 100 HELX_P A ALA 105 A ALA 105 1 HF 6 OXIDOREDUCTASE OXIDOREDUCTASE, INHIBITOR-ENZYME COMPLEX A ARG 52 A ARG 52 1 A PRO 53 A PRO 53 -0.01 A GLY 98 A GLY 98 1 A GLY 99 A GLY 99 -0.02 A ARG 52 A ARG 52 2 A PRO 53 A PRO 53 -0.32 A GLY 98 A GLY 98 2 A GLY 99 A GLY 99 0.14 A ARG 52 A ARG 52 3 A PRO 53 A PRO 53 -0.20 A GLY 98 A GLY 98 3 A GLY 99 A GLY 99 0.03 A ARG 52 A ARG 52 4 A PRO 53 A PRO 53 -0.33 A GLY 98 A GLY 98 4 A GLY 99 A GLY 99 0.05 A ARG 52 A ARG 52 5 A PRO 53 A PRO 53 -0.18 A GLY 98 A GLY 98 5 A GLY 99 A GLY 99 0.00 A ARG 52 A ARG 52 6 A PRO 53 A PRO 53 -0.23 A GLY 98 A GLY 98 6 A GLY 99 A GLY 99 0.11 A ARG 52 A ARG 52 7 A PRO 53 A PRO 53 -0.33 A GLY 98 A GLY 98 7 A GLY 99 A GLY 99 -0.08 A ARG 52 A ARG 52 8 A PRO 53 A PRO 53 -0.14 A GLY 98 A GLY 98 8 A GLY 99 A GLY 99 0.09 A ARG 52 A ARG 52 9 A PRO 53 A PRO 53 -0.25 A GLY 98 A GLY 98 9 A GLY 99 A GLY 99 -0.05 A ARG 52 A ARG 52 10 A PRO 53 A PRO 53 -0.42 A GLY 98 A GLY 98 10 A GLY 99 A GLY 99 0.04 A ARG 52 A ARG 52 11 A PRO 53 A PRO 53 -0.20 A GLY 98 A GLY 98 11 A GLY 99 A GLY 99 -0.01 A ARG 52 A ARG 52 12 A PRO 53 A PRO 53 -0.04 A GLY 98 A GLY 98 12 A GLY 99 A GLY 99 0.07 A ARG 52 A ARG 52 13 A PRO 53 A PRO 53 -0.17 A GLY 98 A GLY 98 13 A GLY 99 A GLY 99 0.03 A ARG 52 A ARG 52 14 A PRO 53 A PRO 53 -0.32 A GLY 98 A GLY 98 14 A GLY 99 A GLY 99 0.00 A ARG 52 A ARG 52 15 A PRO 53 A PRO 53 -0.27 A GLY 98 A GLY 98 15 A GLY 99 A GLY 99 0.14 A ARG 52 A ARG 52 16 A PRO 53 A PRO 53 -0.24 A GLY 98 A GLY 98 16 A GLY 99 A GLY 99 0.00 A ARG 52 A ARG 52 17 A PRO 53 A PRO 53 -0.33 A GLY 98 A GLY 98 17 A GLY 99 A GLY 99 0.06 A ARG 52 A ARG 52 18 A PRO 53 A PRO 53 -0.42 A GLY 98 A GLY 98 18 A GLY 99 A GLY 99 0.07 A ARG 52 A ARG 52 19 A PRO 53 A PRO 53 -0.14 A GLY 98 A GLY 98 19 A GLY 99 A GLY 99 0.02 A ARG 52 A ARG 52 20 A PRO 53 A PRO 53 -0.43 A GLY 98 A GLY 98 20 A GLY 99 A GLY 99 -0.11 A ARG 52 A ARG 52 21 A PRO 53 A PRO 53 -0.35 A GLY 98 A GLY 98 21 A GLY 99 A GLY 99 0.01 DYR_LACCA UNP 1 1 P00381 TAFLWAQDRDGLIGKDGHLPWHLPDDLHYFRAQTVGKIMVVGRRTYESFPKRPLPERTNVVLTHQEDYQAQGAVVVHDVA AVFAYAKQHPDQELVIAGGAQIFTAFKDDVDTLLVTRLAGSFEGDTKMIPLNWDDFTKVSSRTVEDTNPALTHTYEVWQK KA 1 162 1AO8 1 162 P00381 A 1 1 162 8 parallel parallel parallel parallel parallel anti-parallel anti-parallel A VAL 74 A VAL 74 A VAL 76 A VAL 76 A THR 58 A THR 58 A LEU 62 A LEU 62 A ILE 38 A ILE 38 A VAL 41 A VAL 41 A LEU 94 A LEU 94 A GLY 98 A GLY 98 A ALA 2 A ALA 2 A GLN 7 A GLN 7 A THR 112 A THR 112 A LEU 118 A LEU 118 A HIS 153 A HIS 153 A LYS 160 A LYS 160 A PHE 136 A PHE 136 A VAL 144 A VAL 144 BINDING SITE FOR RESIDUE MTX A 170 A MTX 170 Software 13 A LEU 4 A LEU 4 13 1_555 A TRP 5 A TRP 5 13 1_555 A ALA 6 A ALA 6 13 1_555 A LEU 19 A LEU 19 13 1_555 A ASP 26 A ASP 26 13 1_555 A LEU 27 A LEU 27 13 1_555 A PHE 30 A PHE 30 13 1_555 A ARG 31 A ARG 31 13 1_555 A SER 48 A SER 48 13 1_555 A PHE 49 A PHE 49 13 1_555 A ARG 57 A ARG 57 13 1_555 A ALA 97 A ALA 97 13 1_555 A THR 116 A THR 116 13 1_555 1 P 1